| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CTS CORP | Director | Common Stock | 35,913 | $1,434,365 | $39.94 | 06 Nov 2025 | Direct |
| Calidi Biotherapeutics, Inc. | Director | Common Stock | 133,301 | $239,942 | $1.80 | 21 Dec 2023 | Direct |
| AMARIN CORP PLC\UK | Director | Stock Option (Right to Buy) | 115,919 | 27 Jun 2022 | Direct | ||
| AMARIN CORP PLC\UK | Director | Restricted Stock Units | 93,750 | 27 Jun 2022 | Direct | ||
| Syneos Health, Inc. | Director | Class A Common Stock | 0 | $43.00 | 28 Sep 2023 | Direct |